日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lung Cancer and Cardiovascular Disease: Common Pathophysiology and Treatment-Emergent Toxicity

肺癌与心血管疾病:共同的病理生理机制和治疗相关毒性

El-Rayes, Malak; Nardi Agmon, Inbar; Yu, Christopher; Osataphan, Nichanan; Yu, Helena A; Hope, Andrew; Sacher, Adrian; Yu, Anthony F; Abdel-Qadir, Husam; Thavendiranathan, Paaladinesh

Adverse clinical outcomes associated with sickle cell trait at high altitude

高海拔地区镰状细胞性状相关的不良临床结局

Stafford, Katherine A; Osataphan, Soravis; Patell, Rushad; Key, Nigel S

Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation

胰高血糖素样肽-1受体激动剂与2型糖尿病静脉血栓栓塞:Target试验模拟

Chiang, Cho-Han; Song, Junmin; Chang, Yu-Cheng; Osataphan, Soravis; Lee, Yu-Che; Chang, Ko-Yun; Chi, Kuan-Yu; Chiang, Cho-Hung; Dua, Anahita; Lake, Leslie; Lauw, Mandy N; Bauer, Kenneth A; Kazi, Dhruv S; Patell, Rushad

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery

瑞舒伐他汀降低卵巢癌手术后循环组织因子细胞外囊泡的疗效

Osataphan, Soravis; Patell, Rushad; Babuta, Mrigya; Rosovsky, Rachel P; Hisada, Yohei; Edmiston, Charly; Elavalakanar, Pavania; Pfeffer, Michael A; Bregar, Amy; Ramos, Amanda; Garrett, Leslie; Ren, Siyang; Neuberg, Donna; Szabo, Gyongyi; Flaumenhaft, Robert; Mackman, Nigel; Shea, Meghan; Zwicker, Jeffrey I

PD-L1 Expression in Biliary Tract Cancer: Comparison Across Antibody Clones and Role as a Predictor of Response to Chemoimmunotherapy: A Meta-Analysis

PD-L1在胆道癌中的表达:不同抗体克隆间的比较及其作为化疗免疫疗法疗效预测因子的作用:一项荟萃分析

Juarez-Vignon Whaley, Juan J; Osataphan, Soravis; Ponvilawan, Ben; Charoenngam, Nipith; Peters, Mary Linton

Prognostic Role of MTAP Loss in Cholangiocarcinoma

MTAP缺失在胆管癌中的预后作用

Lyon, James; Osataphan, Soravis; Birda, Vaibhav; Russell, Brian; Edmiston, Charly; Paredes, Rodrigo; Rattani, Ahmed; Peters, Mary Linton

Body mass index and type 2 diabetes mellitus as metabolic determinants of immune checkpoint inhibitors response in melanoma

体重指数和2型糖尿病作为黑色素瘤免疫检查点抑制剂反应的代谢决定因素

Jan, Yu Jen Alexander; Chiang, Cho-Han; Osataphan, Soravis; Lawless, Aleigha R; Reynolds, Kerry L; Sullivan, Ryan J

Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients

血液代谢组变化作为多柔比星诱导心脏毒性严重程度和预后的潜在标志物:一项针对HER2阳性和HER2阴性乳腺癌患者的研究

Thonusin, Chanisa; Osataphan, Nichanan; Leemasawat, Krit; Nawara, Wichwara; Sriwichaiin, Sirawit; Supakham, Siriporn; Gunaparn, Siriluck; Apaijai, Nattayaporn; Somwangprasert, Areewan; Phrommintikul, Arintaya; Chattipakorn, Siriporn C; Chattipakorn, Nipon

Anticoagulation for the treatment of immune checkpoint inhibitor-associated venous thromboembolism

抗凝治疗免疫检查点抑制剂相关静脉血栓栓塞症

Chiang, Cho-Han; Osataphan, Soravis; Chang, Yu-Cheng; Chi, Kuan-Yu; Chiang, Cho-Hung; Chang, Yu; Patell, Rushad

Sodium-Glucose Cotransporter 2 Inhibitors During Cancer Therapy: Benefits, Risks, and Ongoing Clinical Trials

癌症治疗期间使用钠-葡萄糖协同转运蛋白2抑制剂:益处、风险和正在进行的临床试验

Osataphan, Nichanan; Abdel-Qadir, Husam; Zebrowska, Agnieszka Maria; Borowiec, Anna